Thomas Andrew Crockett serves as Executive at KalVista Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Thomas Andrew Crockett has executed 58 insider transactions totaling $5.5M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 12, 2019 involved selling 100 shares valued at $1.7K.
Thomas Andrew Crockett currently holds 211,203 shares of KalVista Pharmaceuticals, Inc. (KALV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Andrew Crockett has been a net seller of KALV stock. They have purchased $0 and sold $5.5M worth of shares.
Thomas Andrew Crockett's most recent insider trade was on Dec 12, 2019, when they sold 100 shares at $17.00 per share.
Get notified when new Form 4 filings are submitted
| $17.04 |
| Discretionary |
| Apr 15, 2019 | KALV | $240.2K | Sale | 9,700 | $24.76 | Discretionary |
| Apr 15, 2019 | KALV | $7.8K | Sale | 300 | $25.92 | Discretionary |
| Mar 14, 2019 | KALV | $90.5K | Sale | 3,000 | $30.16 | Discretionary |
| Jan 14, 2019 | KALV | $17.9K | Sale | 901 | $19.86 | Discretionary |
| Jan 14, 2019 | KALV | $175.4K | Sale | 9,099 | $19.28 | Discretionary |
| Nov 21, 2016 | KALV | $0 | Award | 281,420 | $N/A | Discretionary |